SKIN
The Beauty Health Company NASDAQ Listed Nov 24, 2020$0.91
After hrs
$0.60
+3.07%
Mkt Cap $117.9M
52w Low $0.76
7.9% of range
52w High $2.69
50d MA $0.98
200d MA $1.46
P/E (TTM)
-10.8x
EV/EBITDA
9747.5x
P/B
1.8x
Debt/Equity
6.2x
ROE
-15.6%
P/FCF
4.7x
RSI (14)
—
ATR (14)
—
Beta
1.24
50d MA
$0.98
200d MA
$1.46
Avg Volume
733.2K
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
2165 Spring Street · Long Beach, CA 90806 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AMC | -0.07 | -0.06 | +14.3% | 1.06 | +6.6% | +19.8% | +13.2% | +10.4% | +11.3% | +9.4% | — |
| Nov 6, 2025 | AMC | -0.08 | -0.09 | -12.5% | 1.29 | +6.2% | +8.5% | +7.0% | +1.6% | +3.1% | +0.8% | — |
| Aug 7, 2025 | AMC | -0.06 | 0.03 | +150.0% | 1.59 | +27.0% | +18.9% | +39.0% | +45.9% | +49.7% | +36.5% | — |
| May 8, 2025 | AMC | -0.13 | -0.08 | +38.5% | 1.24 | +13.7% | +50.8% | +41.9% | +18.5% | +19.4% | +39.5% | — |
| Mar 12, 2025 | AMC | -0.10 | -0.08 | +20.0% | 1.42 | -9.9% | -5.6% | -7.0% | -7.0% | -9.9% | -7.0% | — |
| Nov 12, 2024 | AMC | -0.12 | -0.15 | -25.0% | 1.70 | +2.9% | +8.8% | +5.3% | -10.0% | -7.6% | -4.7% | — |
| Aug 8, 2024 | AMC | -0.05 | -0.10 | -100.0% | 1.29 | -22.5% | -13.2% | +0.0% | -2.3% | +0.0% | +8.5% | — |
| May 9, 2024 | AMC | -0.14 | -0.10 | +28.6% | 3.59 | -10.9% | -23.7% | -23.7% | -22.0% | -22.8% | -22.8% | — |
| Mar 12, 2024 | AMC | -0.11 | -0.07 | +36.4% | 3.59 | +27.3% | +18.4% | +6.4% | +0.6% | +0.6% | +9.7% | — |
| Nov 13, 2023 | AMC | 0.04 | 0.05 | +17.6% | 3.90 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% | — |
| Aug 9, 2023 | AMC | 0.05 | 0.07 | +40.0% | 7.12 | +1.8% | -0.6% | -1.8% | -7.9% | -13.3% | -15.3% | — |
| May 10, 2023 | AMC | -0.02 | -0.04 | -80.1% | 10.26 | +0.5% | +4.2% | +1.8% | +7.0% | -1.7% | +1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 | TD Cowen | Maintains | Hold → Hold | — | $1.27 | $1.30 | +2.4% | -5.5% | -7.9% | -7.1% | -8.7% | -11.0% |
| Mar 13 | Canaccord Genuity | Maintains | Hold → Hold | — | $1.06 | $1.13 | +6.6% | +19.8% | +13.2% | +10.4% | +11.3% | +9.4% |
| Jan 21 | TD Cowen | Maintains | Hold → Hold | — | $1.44 | $1.44 | +0.0% | +6.9% | +8.3% | +6.2% | +5.6% | +5.6% |
| Sep 22 | TD Cowen | Maintains | Hold → Hold | — | $2.28 | $2.27 | -0.4% | +0.0% | -4.4% | -10.1% | -14.9% | -13.6% |
| Aug 1 | Stifel | Maintains | Hold → Hold | — | $1.54 | $1.52 | -1.3% | -0.6% | +3.9% | +7.1% | +3.2% | +3.2% |
| May 5 | Canaccord Genuity | Maintains | Hold → Hold | — | $1.14 | $1.12 | -1.8% | -7.0% | -7.9% | +24.6% | +8.8% | +64.0% |
| Mar 13 | Canaccord Genuity | Maintains | Hold → Hold | — | $1.42 | $1.28 | -9.9% | -5.6% | -7.0% | -7.0% | -9.9% | -7.0% |
| Nov 13 | Canaccord Genuity | Maintains | Hold → Hold | — | $1.70 | $1.75 | +2.9% | +8.8% | +5.3% | -10.0% | -7.6% | -4.7% |
| Aug 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $1.12 | $1.11 | -0.9% | +15.2% | +12.5% | +15.2% | +25.0% | +25.9% |
| Aug 9 | Piper Sandler | Maintains | Underweight → Underweight | — | $1.29 | $1.00 | -22.5% | -13.2% | +0.0% | -2.3% | +0.0% | +8.5% |
| Jul 26 | Stifel | Maintains | Hold → Hold | — | $1.82 | $1.81 | -0.5% | -1.6% | +2.7% | -1.1% | +1.6% | -6.6% |
| Jul 11 | Piper Sandler | Maintains | Underweight → Underweight | — | $1.76 | $1.74 | -1.1% | +4.5% | +14.2% | +19.9% | +25.0% | +18.2% |
| May 13 | TD Cowen | Maintains | Hold → Hold | — | $2.74 | $2.72 | -0.7% | +0.0% | +2.2% | +1.1% | +1.1% | +0.0% |
| May 13 | DA Davidson | Maintains | Buy → Buy | — | $2.74 | $2.72 | -0.7% | +0.0% | +2.2% | +1.1% | +1.1% | +0.0% |
| May 10 | Piper Sandler | Maintains | Underweight → Underweight | — | $3.59 | $3.20 | -10.9% | -23.7% | -23.7% | -22.0% | -22.8% | -22.8% |
| Mar 15 | DA Davidson | Maintains | Buy → Buy | — | $3.82 | $3.78 | -1.0% | -5.5% | -5.5% | +3.1% | +14.1% | +16.5% |
| Mar 14 | Canaccord Genuity | Maintains | Hold → Hold | — | $4.25 | $4.22 | -0.7% | -10.1% | -15.1% | -15.1% | -7.3% | +2.6% |
| Mar 13 | TD Cowen | Maintains | Market Perform → Market Perform | — | $3.59 | $4.57 | +27.3% | +18.4% | +6.4% | +0.6% | +0.6% | +9.7% |
| Mar 13 | Piper Sandler | Maintains | Underweight → Underweight | — | $3.59 | $4.57 | +27.3% | +18.4% | +6.4% | +0.6% | +0.6% | +9.7% |
| Mar 13 | Stifel | Maintains | Hold → Hold | — | $3.59 | $4.57 | +27.3% | +18.4% | +6.4% | +0.6% | +0.6% | +9.7% |
| Feb 29 | Canaccord Genuity | Maintains | Hold → Hold | — | $3.43 | $3.54 | +3.2% | -2.9% | +8.7% | +6.4% | +0.9% | +1.2% |
| Nov 15 | Jefferies | Downgrade | Buy → Hold | — | $1.39 | $1.46 | +5.0% | +36.7% | +28.1% | +62.6% | +68.3% | +60.4% |
| Nov 14 | Piper Sandler | Downgrade | Overweight → Underweight | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | JP Morgan | Downgrade | Neutral → Underweight | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | William Blair | Downgrade | Outperform → Market Perform | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | Raymond James | Downgrade | Market Perform → Underperform | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | Stifel | Maintains | Hold → Hold | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | TD Cowen | Downgrade | Outperform → Market Perform | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | Canaccord Genuity | Downgrade | Buy → Hold | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Nov 14 | Benchmark | Downgrade | Buy → Hold | — | $3.90 | $1.57 | -59.7% | -64.4% | -51.3% | -54.4% | -42.1% | -40.0% |
| Sep 13 | Benchmark | Maintains | Buy → Buy | — | $6.76 | $6.75 | -0.1% | -1.0% | -0.7% | -0.4% | -9.0% | -10.5% |
| Aug 10 | TD Cowen | Maintains | Outperform → Outperform | — | $7.12 | $7.25 | +1.8% | -0.6% | -1.8% | -7.9% | -13.3% | -15.3% |
| Aug 10 | DA Davidson | Maintains | Buy → Buy | — | $7.12 | $7.25 | +1.8% | -0.6% | -1.8% | -7.9% | -13.3% | -15.3% |
| Aug 8 | Benchmark | Maintains | Buy → Buy | — | $7.63 | $7.48 | -2.0% | -1.3% | -6.7% | -7.2% | -8.4% | -14.0% |
| Jun 21 | Stifel | Downgrade | Buy → Hold | — | $8.70 | $7.70 | -11.5% | -8.3% | -6.8% | -10.7% | -8.6% | -6.3% |
| May 26 | JP Morgan | Maintains | Neutral → Neutral | — | $9.67 | $9.42 | -2.6% | -13.1% | -15.3% | -16.9% | -13.8% | -14.2% |
| May 18 | Benchmark | Maintains | Buy → Buy | — | $10.42 | $10.41 | -0.1% | -2.2% | -1.7% | +0.2% | -4.0% | -8.3% |
| May 11 | DA Davidson | Maintains | Buy → Buy | — | $10.26 | $10.31 | +0.5% | +4.2% | +1.8% | +7.0% | -1.7% | +1.6% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.73 | $11.64 | -0.8% | -1.6% | -0.3% | +3.7% | +7.7% | +13.0% |
| Mar 20 | Exane BNP Paribas | Upgrade | Underperform → Neutral | — | $11.31 | $11.60 | +2.6% | +0.8% | +9.3% | +5.1% | +4.9% | +7.1% |
| Mar 14 | Benchmark | Maintains | Buy → Buy | — | $11.18 | $11.55 | +3.3% | +3.0% | +5.5% | +3.9% | +1.2% | +2.0% |
| Mar 1 | DA Davidson | Maintains | Buy → Buy | — | $12.61 | $12.91 | +2.4% | -2.5% | +0.2% | +1.9% | -4.8% | -6.2% |
| Feb 16 | Cowen & Co. | Maintains | Outperform → Outperform | — | $13.30 | $12.83 | -3.5% | -9.1% | -14.7% | -17.3% | -16.2% | -12.6% |
| Nov 23 | Goldman Sachs | Maintains | Buy → Buy | — | $9.99 | $10.03 | +0.4% | +1.0% | -0.6% | -0.5% | +2.0% | +7.6% |
| Nov 9 | JP Morgan | Downgrade | Overweight → Neutral | — | $10.70 | $10.11 | -5.5% | -21.1% | -10.8% | -7.4% | -4.7% | -2.2% |
| Nov 9 | DA Davidson | Maintains | Buy → Buy | — | $10.70 | $10.11 | -5.5% | -21.1% | -10.8% | -7.4% | -4.7% | -2.2% |
| Sep 28 | DA Davidson | Maintains | Buy → Buy | — | $11.58 | $11.78 | +1.7% | +10.4% | +1.8% | +1.8% | +9.2% | +15.7% |
| Sep 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.57 | $12.71 | +1.1% | -4.7% | -3.2% | -6.1% | -10.0% | -16.4% |
| Sep 16 | DA Davidson | Maintains | Buy → Buy | — | $12.57 | $12.71 | +1.1% | -4.7% | -3.2% | -6.1% | -10.0% | -16.4% |
| Aug 16 | Goldman Sachs | Maintains | Buy → Buy | — | $13.75 | $13.65 | -0.7% | -2.4% | -3.1% | -5.5% | -13.3% | -17.5% |
No insider trades available.
8-K · 5.02
!!! Very High
SkinHealth Systems Inc. -- 8-K 5.02: Executive Change
SkinHealth Systems appointed Kenneth Tripp as director and Dr. Sachin Shridharani as Senior Vice President, signaling management strengthening under new leadership.
Apr 22
8-K
Unknown — 8-K Filing
Skin Inc. achieved fourth-quarter operational improvements driving margin expansion and profitability gains, signaling successful cost management that should enhance shareholder returns and investor confidence.
Mar 12
8-K · 8.01
!! High
SkinHealth Systems Inc. -- 8-K 8.01: Material Event / Announcement
Beauty Health Company settled a consolidated stockholder derivative action in Delaware Court of Chancery, pending court approval, resolving claims related to corporate governance matters without disclosed financial terms.
Mar 6
Data updated apr 27, 2026 1:27am
· Source: massive.com